From an article hosted on Nasdaq.
Would assume that the figure of quarter of a billion people by 2025 having their lives made better, is without the purchase or use of Resapp. Otherwise the figure would be much larger.
(Finally, shares of ResMed gained 13% . The medical device specialist said that fiscal first-quarter revenue and adjusted net income both rose 16% from year-earlier levels. ResMed saw particular strength in its software-as-a-service segment, which benefited from the acquisition of electronic health records specialist MatrixCare. Sleep apnea has been an area of concern in the healthcare community lately, and the company's innovative devices have been instrumental in helping patients confront the disease. ResMed expects to help a quarter billion people make their lives better by 2025, and the company's already well on its way toward reaching that goal.)
RAP Price at posting:
35.0¢ Sentiment: Buy Disclosure: Held
